雪榕生物 (300511.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(雪榕生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 568,629,537.95532,444,483.40842,411,282.63671,087,676.15675,808,928.45397,619,419.04575,916,010.18
 营业收入(元) 568,629,537.95532,444,483.40842,411,282.63671,087,676.15675,808,928.45397,619,419.04575,916,010.18
二、营业总成本(元) 747,576,664.06712,066,248.06611,504,827.66627,611,156.95580,921,644.51581,879,011.87524,517,329.91
 营业成本(元) 619,562,238.19592,970,752.34522,185,617.40585,339,697.96507,108,465.65522,120,737.82457,473,288.80
 研发费用(元) 2,390,612.871,752,608.221,860,518.881,885,403.542,524,972.001,256,224.121,826,764.99
 营业税金及附加(元) 4,995,085.565,105,365.635,197,626.084,256,790.364,543,644.054,705,722.245,323,865.05
 销售费用(元) 27,977,489.1028,903,434.7816,736,831.367,721,147.055,599,567.863,920,911.555,051,513.93
 管理费用(元) 66,222,358.3767,064,945.8945,543,776.8115,953,678.9838,361,969.7726,977,436.0132,305,717.25
 财务费用(元) 26,428,879.9716,269,141.2019,980,457.1312,454,439.0622,783,025.1822,897,980.1322,536,179.89
  其中:利息费用(元) 21,964,782.8321,483,970.6720,723,388.1520,335,769.8323,622,694.1125,490,424.9823,509,808.10
  其中:利息收入(元) 949,878.412,589,726.992,357,881.533,072,338.481,991,315.632,827,911.521,663,229.86
 资产减值损失(元) 142,515.95---398,867,248.98344,491.08-378,915.67-886,824.00
 信用减值损失(元) -777,903.74-552,068.0254,288.32-1,057,645.31-439,601.56-1,372,825.96-227,336.54
三、其他经营收益
 加:投资收益(元) -94,006.46238,191.421,111,314.53-5,352,903.6615,002,848.39-649,700.84-127,921.46
 资产处置收益(元) 1,613,195.13-4,508,447.92-887,420.02-369,973.17-160,683.31-557,846.45181,003.51
 其他收益(元) 1,969,254.122,228,106.302,303,458.94616,653.443,347,780.153,867,711.396,462,755.79
四、营业利润(元) -176,094,071.11-182,774,610.44233,488,096.74-361,554,598.48112,982,118.69-183,351,170.3656,800,357.57
 加:营业外收入(元) 630,967.72-85,003.80565,763.80168,392.91357,042.0710,530,409.7682,392.80
 减:营业外支出(元) 696,054.041,009,903.91465,840.3212,436,270.263,479,621.99413,994.60234,235.49
五、利润总额(元) -176,159,157.43-183,869,518.15233,588,020.22-373,822,475.83109,859,538.77-173,234,755.2056,648,514.88
 减:所得税费用(元) 1,419.03-6,860.01275,433.2613,276,169.035,331,599.16-1,163,016.76-3,878,449.73
六、净利润(元) -176,160,576.46-183,862,658.14233,312,586.96-387,098,644.86104,527,939.61-172,071,738.4460,526,964.61
(一)按经营持续性分类
  持续经营净利润(元) -176,160,576.46-183,862,658.14233,312,586.96-387,098,644.86104,527,939.61-172,071,738.4460,526,964.61
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -169,152,861.04-181,571,357.03222,710,908.61-293,458,103.55107,044,675.06-158,210,256.1057,397,068.93
  少数股东损益(元) -7,007,715.42-2,291,301.1110,601,678.35-93,640,541.31-2,516,735.45-13,861,482.343,129,895.68
 扣除非经常性损益后的净利润(元) -172,377,249.41-178,498,030.76220,096,476.77-287,678,819.3795,874,576.76-169,904,469.1651,118,285.41
七、每股收益
 一、基本每股收益(元) -0.34-0.370.45-0.600.22-0.340.13
 二、稀释每股收益(元) -0.34-0.370.45-0.600.20-0.320.13
八、其他综合收益(元) 1,518,202.68-932,015.0321,997.80502,183.03-1,085,027.329,717.94-221,969.71
 归属于母公司股东的其他综合收益(元) 1,134,914.65-793,370.7713,198.66301,309.83-651,016.395,830.77-133,181.83
 归属于少数股东的其他综合收益(元) 383,288.03-138,644.268,799.14200,873.20-434,010.933,887.17-88,787.88
九、综合收益总额(元) -174,642,373.78-184,794,673.17233,334,584.76-386,596,461.83103,442,912.29-172,062,020.5060,304,994.90
 归属于母公司所有者的综合收益总额(元) -168,017,946.39-182,364,727.80222,724,107.27-293,156,793.72106,393,658.67-158,204,425.3357,263,887.10
 归属于少数股东的综合收益总额(元) -6,624,427.39-2,429,945.3710,610,477.49-93,439,668.11-2,950,746.38-13,857,595.173,041,107.80
公告日期 2023-10-282023-08-302023-04-262023-04-262022-10-262022-08-302022-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院